Colleague, Hear an Update on Psychedelics in Psychiatry in This Upcoming Session

Registration is Open | Join Us!
Featured Session: Are we there yet? An Update on Psychedelics in Psychiatry


Colleague, psychedelics are redefining the landscape of psychiatric care, offering promising interventions for conditions like depression, PTSD, and addiction. In this featured session, you'll learn about emerging research on compounds such as ibogaine, DMT, and 5-MeO-DMT, as well as data from leading clinical trials. 

Join us for an upcoming Psych Congress Regionals meeting to explore the growing therapeutic applications of psychedelics beyond major depressive disorder while gaining practical insights into their use for treating substance use disorders and generalized anxiety. This session will also address the growing divide between medical, personal, and decriminalized uses of psychedelics, equipping clinicians like you with the knowledge to navigate this evolving field responsibly and effectively. Register today!


FEATURED SESSION SPEAKER:

Andrew Penn (2)
Andrew Penn, MS, PMHNP-BC
Clinical Professor of Psychiatry and Nursing University of Illinois Chicago
 

Choose from six complimentary online meetings in 2025. Which date works best for you?

April 3-4, ET

Register Now!
May 1-2, CT

Register Now!
July 17-18, PT

Register Now!
August 7-8, ET

Register Now!
October 9-10, CT

Register Now!
November 20-21, PT

Register Now!

Continuing Education
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please visit the accreditation page for full accreditation details, including credit types and totals, for this activity.

 

 

 


Comments